新型慢性潜在抗抑郁药1-[3-(二甲氨基)丙基]-5-甲基-3-苯基-1H-吲唑(FS32)及其N-去甲基化化合物(FS97)对大鼠脑单胺能受体敏感性的影响。 - Suppr | 超能文献

Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.

作者信息

Koide T, Matsushita H

出版信息

Neuropharmacology. 1981 Mar;20(3):285-92. doi: 10.1016/0028-3908(81)90135-0.

DOI:10.1016/0028-3908(81)90135-0

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.新型慢性潜在抗抑郁药1-[3-(二甲氨基)丙基]-5-甲基-3-苯基-1H-吲唑(FS32)及其N-去甲基化化合物(FS97)对大鼠脑单胺能受体敏感性的影响。

Neuropharmacology. 1981 Mar;20(3):285-92. doi: 10.1016/0028-3908(81)90135-0.

2

Preferential inhibition of type B-MAO by new compounds, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1h-indazole(Fs32) and its N-desmethylated derivative (FS97).新型化合物1-[3-(二甲基氨基)丙基]-5-甲基-3-苯基-1H-吲唑(Fs32)及其N-去甲基化衍生物(FS97)对B型单胺氧化酶的选择性抑制作用

Neuropharmacology. 1980 Sep;19(9):871-5. doi: 10.1016/0028-3908(80)90086-6.

3

Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.新型非三环类抗抑郁药FS32和FS97对（3H）-多巴胺摄取到大鼠脑突触体的抑制作用。

Eur J Pharmacol. 1980 Mar 21;62(2-3):147-55. doi: 10.1016/0014-2999(80)90271-x.

4

Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).一种新型抗抑郁药1-[3-(二甲基氨基)丙基]-5-甲基-3-苯基-1H-吲唑(FS-32)的药理学研究

Arzneimittelforschung. 1979;29(3):511-20.

5

Indazoles as indole bioisosteres: synthesis and evaluation of the tropanyl ester and amide of indazole-3-carboxylate as antagonists at the serotonin 5HT3 receptor.作为吲哚生物电子等排体的吲唑：吲唑-3-羧酸酯的托烷酯和酰胺作为5-羟色胺5HT3受体拮抗剂的合成与评价

J Med Chem. 1987 Sep;30(9):1535-7. doi: 10.1021/jm00392a001.

6

Chronic antidepressant treatment and mouse brain 3H-imipramine binding.慢性抗抑郁药治疗与小鼠脑3H-丙咪嗪结合

J Neurosci Res. 1986;16(2):429-38. doi: 10.1002/jnr.490160210.

7

Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors.3-芳基-1-[(4-苯基-1-哌嗪基)丁基]吲唑衍生物的合成及其对5-羟色胺1A受体和多巴胺D1受体的亲和力。

Pharmazie. 1999 Feb;54(2):99-101.

8

Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.氚标记的1-甲基-N-（8-甲基-8-氮杂双环[3.2.1]辛-3-基）-1H-吲唑-3-甲酰胺的合成及生化评价，一种用于5HT3受体的有用放射性配体。

J Med Chem. 1990 Dec;33(12):3176-81. doi: 10.1021/jm00174a013.

9

Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in spontaneously hypertensive and Wistar-Kyoto rats.地昔帕明（而非氟西汀或丙咪嗪）对自发性高血压大鼠和Wistar-Kyoto大鼠的应变依赖性神经化学和神经内分泌作用。

Neuropharmacology. 2000 Sep;39(12):2464-77. doi: 10.1016/s0028-3908(00)00088-5.

10

Enhancement of serotonin 2C receptor mRNA expression by antidepressants possessing the receptor-blocking activity in the rat brain.具有5-羟色胺2C受体阻断活性的抗抑郁药对大鼠脑内5-羟色胺2C受体信使核糖核酸表达的增强作用。

Jpn J Pharmacol. 1998 Dec;78(4):515-7. doi: 10.1254/jjp.78.515.

引用本文的文献

1

Innovative cascade reaction for 2H-indazole derivative synthesis.用于合成2H-吲唑衍生物的创新级联反应。

Mol Divers. 2025 Feb;29(1):551-559. doi: 10.1007/s11030-024-10874-0. Epub 2024 May 26.

2

Antidepressants and serotonergic neurotransmission: an integrative review.抗抑郁药与血清素能神经传递：一项综合综述。

Psychopharmacology (Berl). 1985;85(4):387-404. doi: 10.1007/BF00429653.